nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydroxyurea—RRM2—uterine cancer	0.765	1	CbGaD
Hydroxyurea—RRM1—Nucleotide Metabolism—POLD1—uterine cancer	0.00463	0.0988	CbGpPWpGaD
Hydroxyurea—RRM1—Synthesis and interconversion of nucleotide di- and triphosphates—RRM2—uterine cancer	0.00403	0.086	CbGpPWpGaD
Hydroxyurea—RRM1—Nucleotide Metabolism—RRM2—uterine cancer	0.00386	0.0823	CbGpPWpGaD
Hydroxyurea—RRM2—Nucleotide Metabolism—POLD1—uterine cancer	0.00381	0.0813	CbGpPWpGaD
Hydroxyurea—RRM2—myometrium—uterine cancer	0.00327	0.0695	CbGeAlD
Hydroxyurea—RRM1—myometrium—uterine cancer	0.00272	0.0578	CbGeAlD
Hydroxyurea—RRM2—uterine cervix—uterine cancer	0.00254	0.0541	CbGeAlD
Hydroxyurea—RRM1—Fluoropyrimidine Activity—RRM2—uterine cancer	0.00248	0.0529	CbGpPWpGaD
Hydroxyurea—RRM2—decidua—uterine cancer	0.00242	0.0516	CbGeAlD
Hydroxyurea—RRM2—renal system—uterine cancer	0.00238	0.0506	CbGeAlD
Hydroxyurea—RRM2—endometrium—uterine cancer	0.0023	0.0489	CbGeAlD
Hydroxyurea—RRM2—mammalian vulva—uterine cancer	0.00223	0.0473	CbGeAlD
Hydroxyurea—RRM2—uterus—uterine cancer	0.00212	0.0451	CbGeAlD
Hydroxyurea—RRM1—uterine cervix—uterine cancer	0.00211	0.045	CbGeAlD
Hydroxyurea—RRM1—smooth muscle tissue—uterine cancer	0.00205	0.0437	CbGeAlD
Hydroxyurea—RRM1—decidua—uterine cancer	0.00201	0.0428	CbGeAlD
Hydroxyurea—RRM1—renal system—uterine cancer	0.00198	0.0421	CbGeAlD
Hydroxyurea—RRM1—endometrium—uterine cancer	0.00191	0.0407	CbGeAlD
Hydroxyurea—RRM2—female reproductive system—uterine cancer	0.00191	0.0405	CbGeAlD
Hydroxyurea—RRM1—mammalian vulva—uterine cancer	0.00185	0.0393	CbGeAlD
Hydroxyurea—RRM1—uterus—uterine cancer	0.00176	0.0375	CbGeAlD
Hydroxyurea—RRM2—female gonad—uterine cancer	0.00173	0.0369	CbGeAlD
Hydroxyurea—RRM2—vagina—uterine cancer	0.00172	0.0367	CbGeAlD
Hydroxyurea—RRM1—female reproductive system—uterine cancer	0.00158	0.0337	CbGeAlD
Hydroxyurea—RRM1—female gonad—uterine cancer	0.00144	0.0307	CbGeAlD
Hydroxyurea—RRM1—vagina—uterine cancer	0.00143	0.0305	CbGeAlD
Hydroxyurea—RRM1—Retinoblastoma (RB) in Cancer—MSH6—uterine cancer	0.00139	0.0296	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—MAP3K4—uterine cancer	0.00136	0.029	CbGpPWpGaD
Hydroxyurea—RRM1—E2F transcription factor network—RRM2—uterine cancer	0.00131	0.0281	CbGpPWpGaD
Hydroxyurea—RRM1—Fluoropyrimidine Activity—MTHFR—uterine cancer	0.00125	0.0268	CbGpPWpGaD
Hydroxyurea—RRM1—Nucleotide metabolism—RRM2—uterine cancer	0.00125	0.0266	CbGpPWpGaD
Hydroxyurea—RRM2—Retinoblastoma (RB) in Cancer—MSH6—uterine cancer	0.00114	0.0244	CbGpPWpGaD
Hydroxyurea—RRM1—Retinoblastoma (RB) in Cancer—RRM2—uterine cancer	0.00114	0.0244	CbGpPWpGaD
Hydroxyurea—RRM2—lymph node—uterine cancer	0.00111	0.0237	CbGeAlD
Hydroxyurea—RRM2—Fluoropyrimidine Activity—MTHFR—uterine cancer	0.00103	0.022	CbGpPWpGaD
Hydroxyurea—RRM1—lymph node—uterine cancer	0.000926	0.0197	CbGeAlD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—INHBA—uterine cancer	0.000759	0.0162	CbGpPWpGaD
Hydroxyurea—CYP2D6—renal system—uterine cancer	0.000587	0.0125	CbGeAlD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—EZH2—uterine cancer	0.000487	0.0104	CbGpPWpGaD
Hydroxyurea—RRM1—Fluoropyrimidine Activity—TP53—uterine cancer	0.000476	0.0102	CbGpPWpGaD
Hydroxyurea—CYP2D6—female reproductive system—uterine cancer	0.00047	0.01	CbGeAlD
Hydroxyurea—RRM1—E2F transcription factor network—CDKN2A—uterine cancer	0.000453	0.00968	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—ESR2—uterine cancer	0.000451	0.00963	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—MLH3—uterine cancer	0.000438	0.00934	CbGpPWpGaD
Hydroxyurea—CYP2D6—female gonad—uterine cancer	0.000428	0.0091	CbGeAlD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—STK11—uterine cancer	0.00041	0.00874	CbGpPWpGaD
Hydroxyurea—RRM1—E2F transcription factor network—CDKN1B—uterine cancer	0.000401	0.00857	CbGpPWpGaD
Hydroxyurea—RRM2—Mitotic G1-G1/S phases—CDKN2B—uterine cancer	0.000399	0.00852	CbGpPWpGaD
Hydroxyurea—RRM2—Fluoropyrimidine Activity—TP53—uterine cancer	0.000392	0.00837	CbGpPWpGaD
Hydroxyurea—RRM2—E2F transcription factor network—CDKN2A—uterine cancer	0.000373	0.00797	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—CDKN2B—uterine cancer	0.000367	0.00784	CbGpPWpGaD
Hydroxyurea—RRM1—E2F transcription factor network—EP300—uterine cancer	0.000353	0.00752	CbGpPWpGaD
Hydroxyurea—RRM1—Retinoblastoma (RB) in Cancer—CDKN1B—uterine cancer	0.000349	0.00745	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—NDC80—uterine cancer	0.000342	0.00731	CbGpPWpGaD
Hydroxyurea—RRM2—E2F transcription factor network—CDKN1B—uterine cancer	0.000331	0.00706	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—NDC80—uterine cancer	0.000306	0.00653	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—POLD1—uterine cancer	0.000291	0.00621	CbGpPWpGaD
Hydroxyurea—RRM2—E2F transcription factor network—EP300—uterine cancer	0.00029	0.0062	CbGpPWpGaD
Hydroxyurea—RRM2—Retinoblastoma (RB) in Cancer—CDKN1B—uterine cancer	0.000287	0.00613	CbGpPWpGaD
Hydroxyurea—Skin ulcer—Epirubicin—uterine cancer	0.00028	0.00198	CcSEcCtD
Hydroxyurea—Blister—Doxorubicin—uterine cancer	0.00028	0.00198	CcSEcCtD
Hydroxyurea—Discomfort—Progesterone—uterine cancer	0.00028	0.00198	CcSEcCtD
Hydroxyurea—Ill-defined disorder—Medroxyprogesterone Acetate—uterine cancer	0.00028	0.00198	CcSEcCtD
Hydroxyurea—Anaemia—Medroxyprogesterone Acetate—uterine cancer	0.000279	0.00197	CcSEcCtD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—ESR1—uterine cancer	0.000274	0.00584	CbGpPWpGaD
Hydroxyurea—Malaise—Medroxyprogesterone Acetate—uterine cancer	0.000272	0.00192	CcSEcCtD
Hydroxyurea—Oedema—Progesterone—uterine cancer	0.000272	0.00192	CcSEcCtD
Hydroxyurea—Infection—Progesterone—uterine cancer	0.00027	0.0019	CcSEcCtD
Hydroxyurea—Nervous system disorder—Progesterone—uterine cancer	0.000266	0.00188	CcSEcCtD
Hydroxyurea—Skin disorder—Progesterone—uterine cancer	0.000264	0.00186	CcSEcCtD
Hydroxyurea—Convulsion—Medroxyprogesterone Acetate—uterine cancer	0.000261	0.00184	CcSEcCtD
Hydroxyurea—RRM2—Cell Cycle—POLD1—uterine cancer	0.00026	0.00556	CbGpPWpGaD
Hydroxyurea—Skin ulcer—Doxorubicin—uterine cancer	0.000259	0.00183	CcSEcCtD
Hydroxyurea—Anorexia—Progesterone—uterine cancer	0.000259	0.00183	CcSEcCtD
Hydroxyurea—Unspecified disorder of skin and subcutaneous tissue—Medroxyprogesterone Acetate—uterine cancer	0.000255	0.0018	CcSEcCtD
Hydroxyurea—Discomfort—Medroxyprogesterone Acetate—uterine cancer	0.000254	0.00179	CcSEcCtD
Hydroxyurea—Amenorrhoea—Epirubicin—uterine cancer	0.000248	0.00175	CcSEcCtD
Hydroxyurea—Oedema—Medroxyprogesterone Acetate—uterine cancer	0.000246	0.00174	CcSEcCtD
Hydroxyurea—Infection—Medroxyprogesterone Acetate—uterine cancer	0.000244	0.00173	CcSEcCtD
Hydroxyurea—Chills—Dactinomycin—uterine cancer	0.000242	0.00171	CcSEcCtD
Hydroxyurea—Dyspnoea—Progesterone—uterine cancer	0.000242	0.00171	CcSEcCtD
Hydroxyurea—Somnolence—Progesterone—uterine cancer	0.000241	0.0017	CcSEcCtD
Hydroxyurea—Nervous system disorder—Medroxyprogesterone Acetate—uterine cancer	0.000241	0.0017	CcSEcCtD
Hydroxyurea—Thrombocytopenia—Medroxyprogesterone Acetate—uterine cancer	0.000241	0.0017	CcSEcCtD
Hydroxyurea—RRM2—G1/S Transition—CDKN1B—uterine cancer	0.00024	0.00512	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—NDUFB11—uterine cancer	0.000239	0.00511	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—SRD5A2—uterine cancer	0.000239	0.00511	CbGpPWpGaD
Hydroxyurea—Dyspepsia—Progesterone—uterine cancer	0.000239	0.00169	CcSEcCtD
Hydroxyurea—Skin disorder—Medroxyprogesterone Acetate—uterine cancer	0.000239	0.00169	CcSEcCtD
Hydroxyurea—Alopecia—Dactinomycin—uterine cancer	0.000239	0.00169	CcSEcCtD
Hydroxyurea—Decreased appetite—Progesterone—uterine cancer	0.000236	0.00167	CcSEcCtD
Hydroxyurea—Hyperuricaemia—Epirubicin—uterine cancer	0.000235	0.00166	CcSEcCtD
Hydroxyurea—Erythema—Dactinomycin—uterine cancer	0.000235	0.00166	CcSEcCtD
Hydroxyurea—Anorexia—Medroxyprogesterone Acetate—uterine cancer	0.000235	0.00166	CcSEcCtD
Hydroxyurea—Gastrointestinal disorder—Progesterone—uterine cancer	0.000234	0.00166	CcSEcCtD
Hydroxyurea—Fatigue—Progesterone—uterine cancer	0.000234	0.00165	CcSEcCtD
Hydroxyurea—Pain—Progesterone—uterine cancer	0.000232	0.00164	CcSEcCtD
Hydroxyurea—Constipation—Progesterone—uterine cancer	0.000232	0.00164	CcSEcCtD
Hydroxyurea—Pancytopenia—Etoposide—uterine cancer	0.000232	0.00164	CcSEcCtD
Hydroxyurea—Ulcer—Epirubicin—uterine cancer	0.000231	0.00163	CcSEcCtD
Hydroxyurea—Amenorrhoea—Doxorubicin—uterine cancer	0.00023	0.00162	CcSEcCtD
Hydroxyurea—Creatinine increased—Epirubicin—uterine cancer	0.000229	0.00162	CcSEcCtD
Hydroxyurea—Neutropenia—Etoposide—uterine cancer	0.000228	0.00161	CcSEcCtD
Hydroxyurea—RRM2—Mitotic G1-G1/S phases—CDKN2A—uterine cancer	0.000228	0.00487	CbGpPWpGaD
Hydroxyurea—Feeling abnormal—Progesterone—uterine cancer	0.000224	0.00158	CcSEcCtD
Hydroxyurea—Blood uric acid increased—Epirubicin—uterine cancer	0.000222	0.00157	CcSEcCtD
Hydroxyurea—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	0.000221	0.00471	CbGpPWpGaD
Hydroxyurea—Dyspnoea—Medroxyprogesterone Acetate—uterine cancer	0.000219	0.00155	CcSEcCtD
Hydroxyurea—RRM1—Retinoblastoma (RB) in Cancer—TP53—uterine cancer	0.000219	0.00468	CbGpPWpGaD
Hydroxyurea—Somnolence—Medroxyprogesterone Acetate—uterine cancer	0.000219	0.00154	CcSEcCtD
Hydroxyurea—Ill-defined disorder—Dactinomycin—uterine cancer	0.000218	0.00154	CcSEcCtD
Hydroxyurea—Infestation NOS—Etoposide—uterine cancer	0.000218	0.00154	CcSEcCtD
Hydroxyurea—Infestation—Etoposide—uterine cancer	0.000218	0.00154	CcSEcCtD
Hydroxyurea—CYP2D6—Oxidation by Cytochrome P450—CYP11A1—uterine cancer	0.000218	0.00465	CbGpPWpGaD
Hydroxyurea—Hyperuricaemia—Doxorubicin—uterine cancer	0.000218	0.00154	CcSEcCtD
Hydroxyurea—Anaemia—Dactinomycin—uterine cancer	0.000217	0.00153	CcSEcCtD
Hydroxyurea—Dyspepsia—Medroxyprogesterone Acetate—uterine cancer	0.000217	0.00153	CcSEcCtD
Hydroxyurea—Body temperature increased—Progesterone—uterine cancer	0.000215	0.00152	CcSEcCtD
Hydroxyurea—Decreased appetite—Medroxyprogesterone Acetate—uterine cancer	0.000214	0.00151	CcSEcCtD
Hydroxyurea—Ulcer—Doxorubicin—uterine cancer	0.000214	0.00151	CcSEcCtD
Hydroxyurea—Neuropathy peripheral—Etoposide—uterine cancer	0.000214	0.00151	CcSEcCtD
Hydroxyurea—Gastrointestinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.000212	0.0015	CcSEcCtD
Hydroxyurea—Stomatitis—Etoposide—uterine cancer	0.000212	0.0015	CcSEcCtD
Hydroxyurea—Creatinine increased—Doxorubicin—uterine cancer	0.000212	0.0015	CcSEcCtD
Hydroxyurea—Fatigue—Medroxyprogesterone Acetate—uterine cancer	0.000212	0.0015	CcSEcCtD
Hydroxyurea—Malaise—Dactinomycin—uterine cancer	0.000212	0.0015	CcSEcCtD
Hydroxyurea—Leukopenia—Dactinomycin—uterine cancer	0.000211	0.00149	CcSEcCtD
Hydroxyurea—Constipation—Medroxyprogesterone Acetate—uterine cancer	0.00021	0.00149	CcSEcCtD
Hydroxyurea—Skin exfoliation—Epirubicin—uterine cancer	0.000208	0.00147	CcSEcCtD
Hydroxyurea—Blood urea increased—Epirubicin—uterine cancer	0.000206	0.00145	CcSEcCtD
Hydroxyurea—Hepatobiliary disease—Etoposide—uterine cancer	0.000206	0.00145	CcSEcCtD
Hydroxyurea—Blood uric acid increased—Doxorubicin—uterine cancer	0.000206	0.00145	CcSEcCtD
Hydroxyurea—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.000203	0.00143	CcSEcCtD
Hydroxyurea—RRM2—Mitotic G1-G1/S phases—CDKN1B—uterine cancer	0.000202	0.00432	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	0.000201	0.00429	CbGpPWpGaD
Hydroxyurea—Hypersensitivity—Progesterone—uterine cancer	0.0002	0.00141	CcSEcCtD
Hydroxyurea—Rash maculo-papular—Epirubicin—uterine cancer	0.000198	0.0014	CcSEcCtD
Hydroxyurea—Discomfort—Dactinomycin—uterine cancer	0.000198	0.0014	CcSEcCtD
Hydroxyurea—Neoplasm—Epirubicin—uterine cancer	0.000197	0.00139	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—SRD5A2—uterine cancer	0.000197	0.00421	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—NDUFB11—uterine cancer	0.000197	0.00421	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—YWHAE—uterine cancer	0.000195	0.00416	CbGpPWpGaD
Hydroxyurea—Asthenia—Progesterone—uterine cancer	0.000195	0.00138	CcSEcCtD
Hydroxyurea—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.000195	0.00137	CcSEcCtD
Hydroxyurea—Pulmonary oedema—Epirubicin—uterine cancer	0.000194	0.00137	CcSEcCtD
Hydroxyurea—Skin exfoliation—Doxorubicin—uterine cancer	0.000193	0.00136	CcSEcCtD
Hydroxyurea—RRM2—Cell Cycle—MLH1—uterine cancer	0.000193	0.00411	CbGpPWpGaD
Hydroxyurea—Oedema—Dactinomycin—uterine cancer	0.000192	0.00136	CcSEcCtD
Hydroxyurea—Infection—Dactinomycin—uterine cancer	0.000191	0.00135	CcSEcCtD
Hydroxyurea—Blood urea increased—Doxorubicin—uterine cancer	0.000191	0.00135	CcSEcCtD
Hydroxyurea—Thrombocytopenia—Dactinomycin—uterine cancer	0.000188	0.00133	CcSEcCtD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	0.000186	0.00397	CbGpPWpGaD
Hydroxyurea—Diarrhoea—Progesterone—uterine cancer	0.000186	0.00131	CcSEcCtD
Hydroxyurea—Rash maculo-papular—Doxorubicin—uterine cancer	0.000184	0.0013	CcSEcCtD
Hydroxyurea—Anorexia—Dactinomycin—uterine cancer	0.000183	0.00129	CcSEcCtD
Hydroxyurea—Neoplasm—Doxorubicin—uterine cancer	0.000183	0.00129	CcSEcCtD
Hydroxyurea—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.000181	0.00128	CcSEcCtD
Hydroxyurea—RRM2—Retinoblastoma (RB) in Cancer—TP53—uterine cancer	0.000181	0.00385	CbGpPWpGaD
Hydroxyurea—Pulmonary oedema—Doxorubicin—uterine cancer	0.00018	0.00127	CcSEcCtD
Hydroxyurea—Dizziness—Progesterone—uterine cancer	0.00018	0.00127	CcSEcCtD
Hydroxyurea—CYP2D6—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	0.000179	0.00382	CbGpPWpGaD
Hydroxyurea—Angiopathy—Etoposide—uterine cancer	0.000177	0.00125	CcSEcCtD
Hydroxyurea—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.000177	0.00125	CcSEcCtD
Hydroxyurea—Hepatic failure—Epirubicin—uterine cancer	0.000176	0.00124	CcSEcCtD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	0.000176	0.00375	CbGpPWpGaD
Hydroxyurea—Chills—Etoposide—uterine cancer	0.000175	0.00124	CcSEcCtD
Hydroxyurea—RRM2—Cell Cycle—YWHAE—uterine cancer	0.000174	0.00372	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—STAR—uterine cancer	0.000173	0.00369	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—AKR1B1—uterine cancer	0.000173	0.00369	CbGpPWpGaD
Hydroxyurea—Alopecia—Etoposide—uterine cancer	0.000173	0.00122	CcSEcCtD
Hydroxyurea—Vomiting—Progesterone—uterine cancer	0.000173	0.00122	CcSEcCtD
Hydroxyurea—Renal failure acute—Epirubicin—uterine cancer	0.000172	0.00121	CcSEcCtD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	0.000171	0.00366	CbGpPWpGaD
Hydroxyurea—Rash—Progesterone—uterine cancer	0.000171	0.00121	CcSEcCtD
Hydroxyurea—Dermatitis—Progesterone—uterine cancer	0.000171	0.00121	CcSEcCtD
Hydroxyurea—Headache—Progesterone—uterine cancer	0.00017	0.0012	CcSEcCtD
Hydroxyurea—CYP2D6—Metapathway biotransformation—AKR1B10—uterine cancer	0.000168	0.0036	CbGpPWpGaD
Hydroxyurea—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000168	0.00119	CcSEcCtD
Hydroxyurea—Decreased appetite—Dactinomycin—uterine cancer	0.000167	0.00118	CcSEcCtD
Hydroxyurea—Dermatitis bullous—Epirubicin—uterine cancer	0.000166	0.00117	CcSEcCtD
Hydroxyurea—Fatigue—Dactinomycin—uterine cancer	0.000165	0.00117	CcSEcCtD
Hydroxyurea—Pain—Dactinomycin—uterine cancer	0.000164	0.00116	CcSEcCtD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	0.000163	0.00349	CbGpPWpGaD
Hydroxyurea—Hepatic failure—Doxorubicin—uterine cancer	0.000163	0.00115	CcSEcCtD
Hydroxyurea—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000163	0.00115	CcSEcCtD
Hydroxyurea—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	0.000162	0.00346	CbGpPWpGaD
Hydroxyurea—Nausea—Progesterone—uterine cancer	0.000161	0.00114	CcSEcCtD
Hydroxyurea—CYP2D6—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	0.00016	0.00342	CbGpPWpGaD
Hydroxyurea—Renal failure acute—Doxorubicin—uterine cancer	0.000159	0.00112	CcSEcCtD
Hydroxyurea—Feeling abnormal—Dactinomycin—uterine cancer	0.000158	0.00112	CcSEcCtD
Hydroxyurea—Ill-defined disorder—Etoposide—uterine cancer	0.000158	0.00112	CcSEcCtD
Hydroxyurea—Anaemia—Etoposide—uterine cancer	0.000157	0.00111	CcSEcCtD
Hydroxyurea—CYP2D6—Metapathway biotransformation—AKR1B1—uterine cancer	0.000157	0.00334	CbGpPWpGaD
Hydroxyurea—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000156	0.0011	CcSEcCtD
Hydroxyurea—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000155	0.0011	CcSEcCtD
Hydroxyurea—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000155	0.00109	CcSEcCtD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	0.000155	0.0033	CbGpPWpGaD
Hydroxyurea—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000154	0.00109	CcSEcCtD
Hydroxyurea—Malaise—Etoposide—uterine cancer	0.000153	0.00108	CcSEcCtD
Hydroxyurea—Dermatitis bullous—Doxorubicin—uterine cancer	0.000153	0.00108	CcSEcCtD
Hydroxyurea—Face oedema—Epirubicin—uterine cancer	0.000153	0.00108	CcSEcCtD
Hydroxyurea—Leukopenia—Etoposide—uterine cancer	0.000152	0.00108	CcSEcCtD
Hydroxyurea—Body temperature increased—Dactinomycin—uterine cancer	0.000152	0.00107	CcSEcCtD
Hydroxyurea—Blood creatinine increased—Epirubicin—uterine cancer	0.000148	0.00105	CcSEcCtD
Hydroxyurea—Convulsion—Etoposide—uterine cancer	0.000147	0.00104	CcSEcCtD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—CDKN2B—uterine cancer	0.000146	0.00312	CbGpPWpGaD
Hydroxyurea—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000146	0.00103	CcSEcCtD
Hydroxyurea—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.000144	0.00102	CcSEcCtD
Hydroxyurea—Discomfort—Etoposide—uterine cancer	0.000143	0.00101	CcSEcCtD
Hydroxyurea—Breast disorder—Epirubicin—uterine cancer	0.000143	0.00101	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—STAR—uterine cancer	0.000143	0.00304	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—AKR1B1—uterine cancer	0.000143	0.00304	CbGpPWpGaD
Hydroxyurea—Face oedema—Doxorubicin—uterine cancer	0.000142	0.000999	CcSEcCtD
Hydroxyurea—Hypersensitivity—Dactinomycin—uterine cancer	0.000141	0.000998	CcSEcCtD
Hydroxyurea—Infection—Etoposide—uterine cancer	0.000138	0.000974	CcSEcCtD
Hydroxyurea—Asthenia—Dactinomycin—uterine cancer	0.000138	0.000972	CcSEcCtD
Hydroxyurea—Blood creatinine increased—Doxorubicin—uterine cancer	0.000137	0.00097	CcSEcCtD
Hydroxyurea—Thrombocytopenia—Etoposide—uterine cancer	0.000136	0.00096	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—POLD1—uterine cancer	0.000136	0.0029	CbGpPWpGaD
Hydroxyurea—Skin disorder—Etoposide—uterine cancer	0.000135	0.000953	CcSEcCtD
Hydroxyurea—Pancreatitis—Epirubicin—uterine cancer	0.000134	0.000948	CcSEcCtD
Hydroxyurea—Breast disorder—Doxorubicin—uterine cancer	0.000132	0.000935	CcSEcCtD
Hydroxyurea—Anorexia—Etoposide—uterine cancer	0.000132	0.000935	CcSEcCtD
Hydroxyurea—CYP2D6—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	0.000132	0.00281	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	0.000132	0.00281	CbGpPWpGaD
Hydroxyurea—Diarrhoea—Dactinomycin—uterine cancer	0.000131	0.000927	CcSEcCtD
Hydroxyurea—RRM2—Cell Cycle—CDKN2B—uterine cancer	0.000131	0.00279	CbGpPWpGaD
Hydroxyurea—Pancytopenia—Epirubicin—uterine cancer	0.00013	0.000918	CcSEcCtD
Hydroxyurea—Dysuria—Epirubicin—uterine cancer	0.000128	0.000904	CcSEcCtD
Hydroxyurea—Neutropenia—Epirubicin—uterine cancer	0.000128	0.000904	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—AKR1C1—uterine cancer	0.000127	0.00271	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—BIRC5—uterine cancer	0.000126	0.0027	CbGpPWpGaD
Hydroxyurea—Weight increased—Epirubicin—uterine cancer	0.000125	0.00088	CcSEcCtD
Hydroxyurea—Pancreatitis—Doxorubicin—uterine cancer	0.000124	0.000877	CcSEcCtD
Hydroxyurea—Dyspnoea—Etoposide—uterine cancer	0.000124	0.000874	CcSEcCtD
Hydroxyurea—Somnolence—Etoposide—uterine cancer	0.000123	0.000872	CcSEcCtD
Hydroxyurea—Drowsiness—Epirubicin—uterine cancer	0.000122	0.000862	CcSEcCtD
Hydroxyurea—Infestation—Epirubicin—uterine cancer	0.000122	0.000862	CcSEcCtD
Hydroxyurea—Infestation NOS—Epirubicin—uterine cancer	0.000122	0.000862	CcSEcCtD
Hydroxyurea—Vomiting—Dactinomycin—uterine cancer	0.000122	0.000862	CcSEcCtD
Hydroxyurea—Rash—Dactinomycin—uterine cancer	0.000121	0.000854	CcSEcCtD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	0.000121	0.00258	CbGpPWpGaD
Hydroxyurea—Decreased appetite—Etoposide—uterine cancer	0.000121	0.000853	CcSEcCtD
Hydroxyurea—Pancytopenia—Doxorubicin—uterine cancer	0.00012	0.00085	CcSEcCtD
Hydroxyurea—Gastrointestinal disorder—Etoposide—uterine cancer	0.00012	0.000847	CcSEcCtD
Hydroxyurea—Fatigue—Etoposide—uterine cancer	0.00012	0.000846	CcSEcCtD
Hydroxyurea—Neuropathy peripheral—Epirubicin—uterine cancer	0.00012	0.000845	CcSEcCtD
Hydroxyurea—Stomatitis—Epirubicin—uterine cancer	0.000119	0.00084	CcSEcCtD
Hydroxyurea—Pain—Etoposide—uterine cancer	0.000119	0.000839	CcSEcCtD
Hydroxyurea—Constipation—Etoposide—uterine cancer	0.000119	0.000839	CcSEcCtD
Hydroxyurea—Dysuria—Doxorubicin—uterine cancer	0.000118	0.000836	CcSEcCtD
Hydroxyurea—Neutropenia—Doxorubicin—uterine cancer	0.000118	0.000836	CcSEcCtD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	0.000117	0.00249	CbGpPWpGaD
Hydroxyurea—Hepatobiliary disease—Epirubicin—uterine cancer	0.000115	0.000815	CcSEcCtD
Hydroxyurea—Weight increased—Doxorubicin—uterine cancer	0.000115	0.000814	CcSEcCtD
Hydroxyurea—CYP2D6—Metapathway biotransformation—AKR1C1—uterine cancer	0.000115	0.00245	CbGpPWpGaD
Hydroxyurea—Feeling abnormal—Etoposide—uterine cancer	0.000114	0.000808	CcSEcCtD
Hydroxyurea—Nausea—Dactinomycin—uterine cancer	0.000114	0.000805	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—RRM2—uterine cancer	0.000113	0.00242	CbGpPWpGaD
Hydroxyurea—Drowsiness—Doxorubicin—uterine cancer	0.000113	0.000798	CcSEcCtD
Hydroxyurea—Infestation NOS—Doxorubicin—uterine cancer	0.000113	0.000798	CcSEcCtD
Hydroxyurea—Infestation—Doxorubicin—uterine cancer	0.000113	0.000798	CcSEcCtD
Hydroxyurea—RRM2—Cell Cycle—BIRC5—uterine cancer	0.000113	0.00241	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—POLD1—uterine cancer	0.000112	0.00239	CbGpPWpGaD
Hydroxyurea—Neuropathy peripheral—Doxorubicin—uterine cancer	0.000111	0.000782	CcSEcCtD
Hydroxyurea—Haemoglobin—Epirubicin—uterine cancer	0.00011	0.000778	CcSEcCtD
Hydroxyurea—Stomatitis—Doxorubicin—uterine cancer	0.00011	0.000777	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—DCN—uterine cancer	0.00011	0.00235	CbGpPWpGaD
Hydroxyurea—Body temperature increased—Etoposide—uterine cancer	0.00011	0.000775	CcSEcCtD
Hydroxyurea—Haemorrhage—Epirubicin—uterine cancer	0.00011	0.000774	CcSEcCtD
Hydroxyurea—Hepatobiliary disease—Doxorubicin—uterine cancer	0.000107	0.000754	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—AKR1C1—uterine cancer	0.000105	0.00223	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—CYP11A1—uterine cancer	0.000104	0.00221	CbGpPWpGaD
Hydroxyurea—Hypersensitivity—Etoposide—uterine cancer	0.000102	0.000723	CcSEcCtD
Hydroxyurea—Haemoglobin—Doxorubicin—uterine cancer	0.000102	0.00072	CcSEcCtD
Hydroxyurea—Haemorrhage—Doxorubicin—uterine cancer	0.000101	0.000716	CcSEcCtD
Hydroxyurea—CYP2D6—Metapathway biotransformation—GPX3—uterine cancer	0.000101	0.00215	CbGpPWpGaD
Hydroxyurea—Asthenia—Etoposide—uterine cancer	9.97e-05	0.000704	CcSEcCtD
Hydroxyurea—Angiopathy—Epirubicin—uterine cancer	9.94e-05	0.000702	CcSEcCtD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	9.87e-05	0.00211	CbGpPWpGaD
Hydroxyurea—Chills—Epirubicin—uterine cancer	9.83e-05	0.000694	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—AKR1C3—uterine cancer	9.78e-05	0.00209	CbGpPWpGaD
Hydroxyurea—Alopecia—Epirubicin—uterine cancer	9.69e-05	0.000684	CcSEcCtD
Hydroxyurea—Erythema—Epirubicin—uterine cancer	9.54e-05	0.000674	CcSEcCtD
Hydroxyurea—Diarrhoea—Etoposide—uterine cancer	9.5e-05	0.000671	CcSEcCtD
Hydroxyurea—CYP2D6—Biological oxidations—CYP11A1—uterine cancer	9.5e-05	0.00203	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metapathway biotransformation—CYP11A1—uterine cancer	9.37e-05	0.002	CbGpPWpGaD
Hydroxyurea—Angiopathy—Doxorubicin—uterine cancer	9.2e-05	0.00065	CcSEcCtD
Hydroxyurea—Dizziness—Etoposide—uterine cancer	9.19e-05	0.000649	CcSEcCtD
Hydroxyurea—Chills—Doxorubicin—uterine cancer	9.1e-05	0.000642	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—DCN—uterine cancer	9.05e-05	0.00193	CbGpPWpGaD
Hydroxyurea—Alopecia—Doxorubicin—uterine cancer	8.96e-05	0.000633	CcSEcCtD
Hydroxyurea—Ill-defined disorder—Epirubicin—uterine cancer	8.85e-05	0.000625	CcSEcCtD
Hydroxyurea—CYP2D6—Metapathway biotransformation—AKR1C3—uterine cancer	8.85e-05	0.00189	CbGpPWpGaD
Hydroxyurea—Vomiting—Etoposide—uterine cancer	8.83e-05	0.000624	CcSEcCtD
Hydroxyurea—Erythema—Doxorubicin—uterine cancer	8.83e-05	0.000623	CcSEcCtD
Hydroxyurea—Anaemia—Epirubicin—uterine cancer	8.82e-05	0.000623	CcSEcCtD
Hydroxyurea—Rash—Etoposide—uterine cancer	8.76e-05	0.000618	CcSEcCtD
Hydroxyurea—Dermatitis—Etoposide—uterine cancer	8.75e-05	0.000618	CcSEcCtD
Hydroxyurea—Headache—Etoposide—uterine cancer	8.7e-05	0.000614	CcSEcCtD
Hydroxyurea—Malaise—Epirubicin—uterine cancer	8.6e-05	0.000607	CcSEcCtD
Hydroxyurea—Leukopenia—Epirubicin—uterine cancer	8.54e-05	0.000603	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—CYP11A1—uterine cancer	8.53e-05	0.00182	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—CDKN2A—uterine cancer	8.37e-05	0.00179	CbGpPWpGaD
Hydroxyurea—Convulsion—Epirubicin—uterine cancer	8.27e-05	0.000584	CcSEcCtD
Hydroxyurea—Nausea—Etoposide—uterine cancer	8.25e-05	0.000583	CcSEcCtD
Hydroxyurea—Ill-defined disorder—Doxorubicin—uterine cancer	8.19e-05	0.000578	CcSEcCtD
Hydroxyurea—Anaemia—Doxorubicin—uterine cancer	8.16e-05	0.000576	CcSEcCtD
Hydroxyurea—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	8.07e-05	0.00057	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—AKR1C3—uterine cancer	8.05e-05	0.00172	CbGpPWpGaD
Hydroxyurea—Discomfort—Epirubicin—uterine cancer	8.03e-05	0.000567	CcSEcCtD
Hydroxyurea—Malaise—Doxorubicin—uterine cancer	7.96e-05	0.000562	CcSEcCtD
Hydroxyurea—Leukopenia—Doxorubicin—uterine cancer	7.9e-05	0.000558	CcSEcCtD
Hydroxyurea—Oedema—Epirubicin—uterine cancer	7.79e-05	0.00055	CcSEcCtD
Hydroxyurea—Infection—Epirubicin—uterine cancer	7.74e-05	0.000546	CcSEcCtD
Hydroxyurea—Convulsion—Doxorubicin—uterine cancer	7.65e-05	0.00054	CcSEcCtD
Hydroxyurea—Nervous system disorder—Epirubicin—uterine cancer	7.64e-05	0.000539	CcSEcCtD
Hydroxyurea—Thrombocytopenia—Epirubicin—uterine cancer	7.62e-05	0.000538	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—STK11—uterine cancer	7.62e-05	0.00163	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—CYP19A1—uterine cancer	7.62e-05	0.00163	CbGpPWpGaD
Hydroxyurea—Skin disorder—Epirubicin—uterine cancer	7.56e-05	0.000534	CcSEcCtD
Hydroxyurea—RRM2—Cell Cycle—CDKN2A—uterine cancer	7.49e-05	0.0016	CbGpPWpGaD
Hydroxyurea—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	7.46e-05	0.000527	CcSEcCtD
Hydroxyurea—Discomfort—Doxorubicin—uterine cancer	7.43e-05	0.000524	CcSEcCtD
Hydroxyurea—Anorexia—Epirubicin—uterine cancer	7.42e-05	0.000524	CcSEcCtD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—CDKN1B—uterine cancer	7.41e-05	0.00158	CbGpPWpGaD
Hydroxyurea—Oedema—Doxorubicin—uterine cancer	7.2e-05	0.000509	CcSEcCtD
Hydroxyurea—Infection—Doxorubicin—uterine cancer	7.16e-05	0.000505	CcSEcCtD
Hydroxyurea—Nervous system disorder—Doxorubicin—uterine cancer	7.07e-05	0.000499	CcSEcCtD
Hydroxyurea—Thrombocytopenia—Doxorubicin—uterine cancer	7.05e-05	0.000498	CcSEcCtD
Hydroxyurea—Skin disorder—Doxorubicin—uterine cancer	7e-05	0.000494	CcSEcCtD
Hydroxyurea—CYP2D6—Biological oxidations—CYP19A1—uterine cancer	6.99e-05	0.00149	CbGpPWpGaD
Hydroxyurea—Dyspnoea—Epirubicin—uterine cancer	6.94e-05	0.00049	CcSEcCtD
Hydroxyurea—Somnolence—Epirubicin—uterine cancer	6.92e-05	0.000489	CcSEcCtD
Hydroxyurea—CYP2D6—Metapathway biotransformation—CYP19A1—uterine cancer	6.89e-05	0.00147	CbGpPWpGaD
Hydroxyurea—Anorexia—Doxorubicin—uterine cancer	6.87e-05	0.000485	CcSEcCtD
Hydroxyurea—Dyspepsia—Epirubicin—uterine cancer	6.85e-05	0.000484	CcSEcCtD
Hydroxyurea—Decreased appetite—Epirubicin—uterine cancer	6.77e-05	0.000478	CcSEcCtD
Hydroxyurea—Gastrointestinal disorder—Epirubicin—uterine cancer	6.72e-05	0.000475	CcSEcCtD
Hydroxyurea—Fatigue—Epirubicin—uterine cancer	6.71e-05	0.000474	CcSEcCtD
Hydroxyurea—Pain—Epirubicin—uterine cancer	6.66e-05	0.00047	CcSEcCtD
Hydroxyurea—Constipation—Epirubicin—uterine cancer	6.66e-05	0.00047	CcSEcCtD
Hydroxyurea—RRM2—Cell Cycle—CDKN1B—uterine cancer	6.63e-05	0.00142	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—EP300—uterine cancer	6.51e-05	0.00139	CbGpPWpGaD
Hydroxyurea—Dyspnoea—Doxorubicin—uterine cancer	6.42e-05	0.000454	CcSEcCtD
Hydroxyurea—Feeling abnormal—Epirubicin—uterine cancer	6.42e-05	0.000453	CcSEcCtD
Hydroxyurea—Somnolence—Doxorubicin—uterine cancer	6.41e-05	0.000452	CcSEcCtD
Hydroxyurea—Dyspepsia—Doxorubicin—uterine cancer	6.34e-05	0.000448	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—STK11—uterine cancer	6.27e-05	0.00134	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—CYP19A1—uterine cancer	6.27e-05	0.00134	CbGpPWpGaD
Hydroxyurea—Decreased appetite—Doxorubicin—uterine cancer	6.26e-05	0.000442	CcSEcCtD
Hydroxyurea—Gastrointestinal disorder—Doxorubicin—uterine cancer	6.22e-05	0.000439	CcSEcCtD
Hydroxyurea—Fatigue—Doxorubicin—uterine cancer	6.21e-05	0.000439	CcSEcCtD
Hydroxyurea—Pain—Doxorubicin—uterine cancer	6.16e-05	0.000435	CcSEcCtD
Hydroxyurea—Constipation—Doxorubicin—uterine cancer	6.16e-05	0.000435	CcSEcCtD
Hydroxyurea—Body temperature increased—Epirubicin—uterine cancer	6.16e-05	0.000435	CcSEcCtD
Hydroxyurea—Feeling abnormal—Doxorubicin—uterine cancer	5.94e-05	0.000419	CcSEcCtD
Hydroxyurea—RRM2—Cell Cycle—EP300—uterine cancer	5.82e-05	0.00124	CbGpPWpGaD
Hydroxyurea—Hypersensitivity—Epirubicin—uterine cancer	5.74e-05	0.000405	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—MTHFR—uterine cancer	5.73e-05	0.00122	CbGpPWpGaD
Hydroxyurea—Body temperature increased—Doxorubicin—uterine cancer	5.7e-05	0.000402	CcSEcCtD
Hydroxyurea—Asthenia—Epirubicin—uterine cancer	5.59e-05	0.000394	CcSEcCtD
Hydroxyurea—Diarrhoea—Epirubicin—uterine cancer	5.33e-05	0.000376	CcSEcCtD
Hydroxyurea—Hypersensitivity—Doxorubicin—uterine cancer	5.31e-05	0.000375	CcSEcCtD
Hydroxyurea—Asthenia—Doxorubicin—uterine cancer	5.17e-05	0.000365	CcSEcCtD
Hydroxyurea—Dizziness—Epirubicin—uterine cancer	5.15e-05	0.000364	CcSEcCtD
Hydroxyurea—Vomiting—Epirubicin—uterine cancer	4.95e-05	0.00035	CcSEcCtD
Hydroxyurea—Diarrhoea—Doxorubicin—uterine cancer	4.93e-05	0.000348	CcSEcCtD
Hydroxyurea—Rash—Epirubicin—uterine cancer	4.91e-05	0.000347	CcSEcCtD
Hydroxyurea—Dermatitis—Epirubicin—uterine cancer	4.91e-05	0.000346	CcSEcCtD
Hydroxyurea—Headache—Epirubicin—uterine cancer	4.88e-05	0.000344	CcSEcCtD
Hydroxyurea—Dizziness—Doxorubicin—uterine cancer	4.76e-05	0.000336	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—MTHFR—uterine cancer	4.71e-05	0.00101	CbGpPWpGaD
Hydroxyurea—Nausea—Epirubicin—uterine cancer	4.63e-05	0.000327	CcSEcCtD
Hydroxyurea—Vomiting—Doxorubicin—uterine cancer	4.58e-05	0.000323	CcSEcCtD
Hydroxyurea—Rash—Doxorubicin—uterine cancer	4.54e-05	0.000321	CcSEcCtD
Hydroxyurea—Dermatitis—Doxorubicin—uterine cancer	4.54e-05	0.00032	CcSEcCtD
Hydroxyurea—Headache—Doxorubicin—uterine cancer	4.51e-05	0.000319	CcSEcCtD
Hydroxyurea—Nausea—Doxorubicin—uterine cancer	4.28e-05	0.000302	CcSEcCtD
Hydroxyurea—RRM2—Cell Cycle—TP53—uterine cancer	4.17e-05	0.000889	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—NDUFB11—uterine cancer	3.76e-05	0.000802	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—SRD5A2—uterine cancer	3.76e-05	0.000802	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—PTEN—uterine cancer	3.18e-05	0.00068	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—EP300—uterine cancer	3.04e-05	0.000648	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—STAR—uterine cancer	2.72e-05	0.00058	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—AKR1B1—uterine cancer	2.72e-05	0.00058	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—PTEN—uterine cancer	2.62e-05	0.00056	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—EP300—uterine cancer	2.5e-05	0.000534	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—PIK3CA—uterine cancer	2.25e-05	0.00048	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—POLD1—uterine cancer	2.13e-05	0.000455	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—AKR1C1—uterine cancer	1.99e-05	0.000425	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—PIK3CA—uterine cancer	1.85e-05	0.000395	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—AKT1—uterine cancer	1.84e-05	0.000392	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—RRM2—uterine cancer	1.78e-05	0.000379	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—DCN—uterine cancer	1.72e-05	0.000368	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—CYP11A1—uterine cancer	1.62e-05	0.000347	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—AKR1C3—uterine cancer	1.53e-05	0.000327	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—AKT1—uterine cancer	1.51e-05	0.000323	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—CYP19A1—uterine cancer	1.2e-05	0.000255	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—STK11—uterine cancer	1.2e-05	0.000255	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—MTHFR—uterine cancer	8.98e-06	0.000192	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—PTEN—uterine cancer	5e-06	0.000107	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—EP300—uterine cancer	4.77e-06	0.000102	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—PIK3CA—uterine cancer	3.53e-06	7.52e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—AKT1—uterine cancer	2.88e-06	6.15e-05	CbGpPWpGaD
